Supporting the designation of March as "Autoimmune Awareness Month" and supporting efforts to increase awareness of autoimmune diseases and increase funding for autoimmune disease research.
This resolution expresses the House of Representatives' support for designating March as "Autoimmune Awareness Month" . This designation aims to educate the public about autoimmune diseases, which are chronic, often debilitating conditions affecting up to 50 million people in the United States, with a rising prevalence and significant impact on women and children. The resolution highlights that these diseases, numbering over 100, are frequently difficult to diagnose, leading to delayed treatment and potential irreparable damage. Furthermore, the resolution supports the efforts of healthcare providers and patient advocacy organizations to increase awareness of autoimmune disease causes and treatments. It also advocates for a substantial increase in funding for aggressive research to uncover the root causes of these diseases, develop improved diagnostic methods, and find effective treatments for those affected. This comprehensive approach seeks to address the critical need for better understanding and management of autoimmune diseases, where the United States currently lags in research compared to other countries.
Get AI-generated questions to help you understand this bill better
Timeline
Submitted in House
Referred to the House Committee on Energy and Commerce.
Submitted in House
Referred to the House Committee on Energy and Commerce.
Health
Supporting the designation of March as "Autoimmune Awareness Month" and supporting efforts to increase awareness of autoimmune diseases and increase funding for autoimmune disease research.
USA119th CongressHRES-225| House
| Updated: 3/14/2025
This resolution expresses the House of Representatives' support for designating March as "Autoimmune Awareness Month" . This designation aims to educate the public about autoimmune diseases, which are chronic, often debilitating conditions affecting up to 50 million people in the United States, with a rising prevalence and significant impact on women and children. The resolution highlights that these diseases, numbering over 100, are frequently difficult to diagnose, leading to delayed treatment and potential irreparable damage. Furthermore, the resolution supports the efforts of healthcare providers and patient advocacy organizations to increase awareness of autoimmune disease causes and treatments. It also advocates for a substantial increase in funding for aggressive research to uncover the root causes of these diseases, develop improved diagnostic methods, and find effective treatments for those affected. This comprehensive approach seeks to address the critical need for better understanding and management of autoimmune diseases, where the United States currently lags in research compared to other countries.